Skip to content

Clinical trials

Phase 3 Neoplasms trials in Colombia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Country / region: Colombia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20111
20122
20131
20151
20182
20192
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Bayer2
AbbVie1
Astellas Pharma Global Development, Inc.1
Bristol-Myers Squibb1
Celldex Therapeutics1
Colombian Foundation for Epilepsy and Neurological Disease1
Eli Lilly and Company1
Exelixis1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms16
Breast Neoplasms3
Brain Neoplasms2
Breast Diseases2
Carcinoma, Non-Small-Cell Lung2
Neoplasm Metastasis2
Neoplasms by Site2
Skin Diseases2
Adenocarcinoma1
Astrocytoma1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.